,,ib ,union ,calendar ,no4 #dce #aadth ,,congress #b;d ,session ,h4 ,r4 #diha ,report ,no4 #aad-efa1 ,part ,i ,,in ,,the ,,house ,,of ,,representatives ,april #ah1 #bjaf ,mr4 ,bucshon 7for himself and ,mr4 ,tonko7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on the ,judiciary1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,may #aj1 #bjaf;,additional sponsor3 ,mr4 ,rokita ,may #aj1 #bjaf ,reported from the ,committee on ,energy and ,commerce with an amendment ,strike out all after the enacting clause and insert the part printed in italic ,may #aj1 #bjaf,the ,committee on the ,judiciary discharged2 committed to the ,committee of the ,whole ,house on the ,state of the ,union and ordered to be printed,for text of introduced bill1 see copy of bill as introduced on ,april #ah1 #bjaf ,a ,,bill ,to amend the ,controlled ,substances ,act to improve access to opioid use disorder treatment4 #a4 ,short title ,this ,act may be cited as the ,opioid ,use ,disorder ,treatment ,expansion and ,modernization ,act4 #b4 ,finding ,the ,congress finds that opioid use disorder has become a public health epidemic that must be addressed by increasing awareness and access to all treatment options for opioid use disorder1 overdose reversal1 and relapse prevention4 #c4 ,opioid use disorder treatment modernization 7a7 ,in general ,section #cjc7;g77#b7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;g77#b77 is amended-- 7#a7 in subparagraph 7,b71 by striking clauses 7i71 7ii71 and 7iii7 and inserting the following3 7i7 ,the practitioner is a qualifying practitioner 7as defined in subparagraph 7,g774 7ii7 ,with respect to patients to whom the practitioner will provide such drugs or combinations of drugs1 the practitioner has the capacity to provide directly1 by referral1 or in such other manner as determined by the ,secretary-- 7,i7 all schedule ,,iii1 ,,iv1 and ,v drugs1 as well as unscheduled medications approved by the ,food and ,drug ,administration1 for the treatment of opioid use disorder1 including such drugs and medications for maintenance1 detoxification1 overdose reversal1 and relapse prevention1 as available2 and 7,,ii7 appropriate counseling and other appropriate ancillary services4 7iii7 7,i7 ,the total number of such patients of the practitioner at any one time will not exceed the applicable number4 ,except as provided in subclauses 7,,ii7 and 7,,iii71 the applicable number is #cj4 7,,ii7 ,the applicable number is #ajj if1 not sooner than #a year after the date on which the practitioner submitted the initial notification1 the practitioner submits a second notification to the ,secretary of the need and intent of the practitioner to treat up to #ajj patients4 7,,iii7 ,the applicable number is #bej if the practitioner is a qualifying physician meeting the requirement of subclause 7,,vi7 and1 not sooner than #a year after the date on which the physician submitted a second notification under subclause 7,,ii71 the practitioner submits a third notification to the ,secretary of the need and intent of the physician to treat up to #bej patients4 7,,iv7 ,the ,secretary may by regulation change such total number4 7,v7 ,the ,secretary may exclude from the applicable number patients to whom such drugs or combinations of drugs are directly administered by the qualifying practitioner in the office setting4 7,,vi7 ,for purposes of subclause 7,,iii71 a qualifying physician meets the requirement of this subclause if the physician-- 7aa7 holds a special certification in addiction psychiatry or addiction medicine as described in clause 7ii7 from the ,american ,board of ,medical ,specialties1 the ,american ,board of ,addiction ,medicine1 the ,american ,osteopathic ,association1 the ,american ,society of ,addiction ,medicine1 or such other organization as the ,secretary determines to be appropriate for purposes of this subclause2 or 7bb7 has completed not fewer than #bd hours of training1 with respect to the treatment and management of opiate-dependent patients1 addressing the topics listed in subparagraph 7,g77ii77,,iv74 ,the ,secretary may review and update the requirements of this subclause4 7iv7 ,in the case of a third notification under clause 7iii77,,iii71 the qualifying physician maintains and implements a diversion control plan that contains specific measures to reduce the likelihood of the diversion of controlled substances prescribed by the physician for the treatment of opioid use disorder4 7v7 ,in the case of a third notification under clause 7iii77,,iii71 the qualifying physician obtains a written agreement from each patient1 including the patient's signature1 that the patient-- 7,i7 will receive an initial assessment and treatment plan and periodic assessments and treatment plans thereafter2 7,,ii7 will be subject to medication adherence and substance use monitoring2 7,,iii7 understands available treatment options1 including all drugs approved by the ,food and ,drug ,administration for the treatment of opioid use disorder1 including their potential risks and benefits2 and 7,,iv7 understands that receiving regular counseling services is critical to recovery4 7vi7 ,the practitioner will comply with the reporting requirements of subparagraph 7,d77i77,,iv74 2 7#b7 in subparagraph 7,d7-- 7,a7 in clause 7i71 by adding at the end the following3 7,,iv7 ,the practitioner reports to the ,secretary1 at such times and in such manner as specified by the ,secretary1 such information and assurances as the ,secretary determines necessary to assess whether the practitioner continues to meet the requirements for a waiver under this paragraph4 2 7,b7 in clause 7ii71 by striking ,upon receiving a notification under subparagraph 7,b7 and inserting ,upon receiving a determination from the ,secretary under clause 7iii7 finding that a practitioner meets all requirements for a waiver under subparagraph 7,b72 and 7,c7 in clause 7iii7-- 7i7 by inserting and shall forward such determination to the ,attorney ,general before the period at the end of the first sentence2 and 7ii7 by striking physician and inserting practitioner2 7#c7 in subparagraph 7,g7-- 7,a7 by amending clause 7ii77,,iv7 to read as follows3 7,,iv7 ,the physician has1 with respect to the treatment and management of opiate-dependent patients1 completed not less than eight hours of training 7through classroom situations1 seminars at professional society meetings1 electronic communications1 or otherwise7 that is provided by the ,american ,society of ,addiction ,medicine1 the ,american ,academy of ,addiction ,psychiatry1 the ,american ,medical ,association1 the ,american ,osteopathic ,association1 the ,american ,psychiatric ,association1 or any other organization that the ,secretary determines is appropriate for purposes of this subclause4 ,such training shall address-- 7aa7 opioid maintenance and detoxification2 7bb7 appropriate clinical use of all drugs approved by the ,food and ,drug ,administration for the treatment of opioid use disorder2 7cc7 initial and periodic patient assessments 7including substance use monitoring72 7dd7 individualized treatment planning2 overdose reversal2 relapse prevention2 7ee7 counseling and recovery support services2 7ff7 staffing roles and considerations2 7gg7 diversion control2 and 7hh7 other best practices1 as identified by the ,secretary4 2 and 7,b7 by adding at the end the following3 7iii7 ,the term qualifying practitioner means-- 7,i7 a qualifying physician1 as defined in clause 7ii72 or 7,,ii7 a qualifying other practitioner1 as defined in clause 7iv74 7iv7 ,the term qualifying other practitioner means a nurse practitioner or physician assistant who satisfies each of the following3 7,i7 ,the nurse practitioner or physician assistant is licensed under ,state law to prescribe schedule ,,iii1 ,,iv1 or ,v medications for the treatment of pain4 7,,ii7 ,the nurse practitioner or physician assistant satisfies #a or more of the following3 7aa7 ,has completed not fewer than #bd hours of initial training addressing each of the topics listed in clause 7ii77,,iv7 7through classroom situations1 seminars at professional society meetings1 electronic communications1 or otherwise7 provided by the ,american ,society of ,addiction ,medicine1 the ,american ,academy of ,addiction ,psychiatry1 the ,american ,medical ,association1 the ,american ,osteopathic ,association1 the ,american ,nurses ,credentialing ,center1 the ,american ,psychiatric ,association1 the ,american ,association of ,nurse ,practitioners1 the ,american ,academy of ,physician ,assistants1 or any other organization that the ,secretary determines is appropriate for purposes of this subclause4 7bb7 ,has such other training or experience as the ,secretary determines will demonstrate the ability of the nurse practitioner or physician assistant to treat and manage opiate-dependent patients4 7,,iii7 ,the nurse practitioner or physician assistant is supervised by or works in collaboration with a qualifying physician1 if the nurse practitioner or physician assistant is required by ,state law to prescribe medications for the treatment of opioid use disorder in collaboration with or under the supervision of a physician4 ,the ,secretary may review and update the requirements for being a qualifying other practitioner under this clause4 2 and 7#d7 in subparagraph 7,h7-- 7,a7 in clause 7i71 by inserting after subclause 7,,ii7 the following3 7,,iii7 ,such other elements of the requirements under this paragraph as the ,secretary determines necessary for purposes of implementing such requirements4 2 and 7,b7 by amending clause 7ii7 to read as follows3 7ii7 ,not later than one year after the date of enactment of the ,opioid ,use ,disorder ,treatment ,expansion and ,modernization ,act1 the ,secretary shall update the treatment improvement protocol containing best practice guidelines for the treatment of opioid-dependent patients in office-based settings4 ,the ,secretary shall update such protocol in consultation with experts in opioid use disorder research and treatment4 4 7b7 ,recommendation of revocation or suspension of registration in case of substantial noncompliance ,the ,secretary of ,health and ,human ,services may recommend to the ,attorney ,general that the registration of a practitioner be revoked or suspended if the ,secretary determines1 according to such criteria as the ,secretary establishes by regulation1 that a practitioner who is registered under section #cjc7;g77#b7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;g77#b77 is not in substantial compliance with the requirements of such section1 as amended by this ,act4 7c7 ,opioid defined ,section #ajb7ah7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hjb7ah77 is amended by inserting or opioid after ,the term opiate4 7d7 ,reports to ,congress 7#a7 ,in general ,not later than #b years after the date of enactment of this ,act and not less than over every #e years thereafter1 the ,secretary of ,health and ,human ,services1 in consultation with the ,drug ,enforcement ,administration and experts in opioid use disorder research and treatment1 shall-- 7,a7 perform a thorough review of the provision of opioid use disorder treatment services in the ,united ,states1 including services provided in opioid treatment programs and other specialty and nonspecialty settings2 and 7,b7 submit a report to the ,congress on the findings and conclusions of such review4 7#b7 ,contents ,each report under paragraph 7#a7 shall include an assessment of-- 7,a7 compliance with the requirements of section #cjc7;g77#b7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;g77#b771 as amended by this ,act2 7,b7 the measures taken by the ,secretary of ,health and ,human ,services to ensure such compliance2 7,c7 whether there is further need to increase or decrease the number of patients a waivered practitioner is permitted to treat1 as provided for by the amendment made by subsection 7a77#a72 7,d7 the extent to which1 and proportions with which1 the full range of ,food and ,drug ,administration-approved treatments for opioid use disorder are used in routine health care settings and specialty substance use disorder treatment settings2 7,e7 access to1 and use of1 counseling and recovery support services1 including the percentage of patients receiving such services2 7,f7 changes in ,state or local policies and legislation relating to opioid use disorder treatment2 7,g7 the use of prescription drug monitoring programs by practitioners who are permitted to dispense narcotic drugs to individuals pursuant to a waiver under section #cjc7;g77#b7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;g77#b772 7,h7 the findings resulting from inspections by the ,drug ,enforcement ,administration of practitioners described in subparagraph 7,g72 and 7,i7 the effectiveness of cross-agency collaboration between ,department of ,health and ,human ,services and the ,drug ,enforcement ,administration for expanding effective opioid use disorder treatment4 ,may #aj1 #bjaf ,reported from the ,committee on ,energy and ,commerce with an amendment,may #aj1 #bjaf,the ,committee on the ,judiciary discharged2 committed to the ,committee of the ,whole ,house on the ,state of the ,union and ordered to be printed